Not Yet Recruiting
An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD
NCT06022744
- Conditions
- To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
- Locations
-
Not specified